Imunon, Inc.

IMNN · Nasdaq · SIC 2834: Pharmaceutical Preparations
401
SEC Filings

Business Summary

1 FORWARD-LOOKING STATEMENTS 1 OVERVIEW 2 THERAPLAS MODALITY: IMNN-001 DEVELOPMENT PROGRAM 2 Ovarian Cancer Overview 2 IMNN-001 Immunotherapy 3 OVATION I Study 3 OVATION 2 Study 5 OVATION 3 Study 8 IMNN-001 in Combination with Bevacizumab 9 PLACCINE DNA VACCINE MODALITY: IMNN-101 9 Our Next Generation Vaccine Initiative 10 BUSINESS STRATEGY AND DEVELOPMENT PLAN 12 RESEARCH AND DEVELOPMENT EXPENDITURES 13 GOVERNMENT REGULATION 14 MANUFACTURING AND SUPPLY 24 SALES AND MARKETING 24 PRODUCT LIABILIT...

Next Earnings

Q2 FY2026 — expected 2026-08-18

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionIMNNdiscussed_in_filing Cybersecurity
topic_mentionIMNNdiscussed_in_filing Trusted Computing
topic_mentionIMNNdiscussed_in_filing Blockchain & Crypto
topic_mentionIMNNdiscussed_in_filing Supply Chain
topic_mentionIMNNdiscussed_in_filing Regulation
topic_mentionIMNNdiscussed_in_filing Healthcare & Bio
topic_mentionIMNNdiscussed_in_filing Platform & Ecosystem
topic_mentionIMNNdiscussed_in_filing Sovereign & Government
topic_mentionIMNNdiscussed_in_filing Cybersecurity
topic_mentionIMNNdiscussed_in_filing Trusted Computing
topic_mentionIMNNdiscussed_in_filing Blockchain & Crypto
topic_mentionIMNNdiscussed_in_filing Supply Chain
topic_mentionIMNNdiscussed_in_filing Regulation
topic_mentionIMNNdiscussed_in_filing Healthcare & Bio
topic_mentionIMNNdiscussed_in_filing Platform & Ecosystem
topic_mentionIMNNdiscussed_in_filing Sovereign & Government
topic_mentionIMNNdiscussed_in_filing Cybersecurity
topic_mentionIMNNdiscussed_in_filing Trusted Computing
topic_mentionIMNNdiscussed_in_filing Blockchain & Crypto
topic_mentionIMNNdiscussed_in_filing Supply Chain

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-312025-12-310001493152-26-013850EDGAR74K words
2025-02-272024-12-310001493152-25-008460EDGAR
2024-03-282023-12-310001493152-24-011616EDGAR
2023-03-302022-12-310001493152-23-009604EDGAR
2022-03-312021-12-310001493152-22-008277EDGAR
2021-03-192020-12-310001493152-21-006382EDGAR
2020-03-252019-12-310001493152-20-004717EDGAR
2019-03-292018-12-310001493152-19-004184EDGAR
2018-03-272017-12-310001437749-18-005539EDGAR
2017-03-242016-12-310001437749-17-005235EDGAR

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-132025-09-300001493152-25-022120EDGAR26K words
2025-08-052025-06-300001493152-25-011598EDGAR
2025-05-122025-03-310001641172-25-009572EDGAR
2024-11-072024-09-300001493152-24-043931EDGAR
2024-08-142024-06-300001493152-24-031916EDGAR
2024-05-132024-03-310001493152-24-018795EDGAR
2023-11-142023-09-300001493152-23-040803EDGAR
2023-08-102023-06-300001493152-23-027457EDGAR
2023-05-112023-03-310001493152-23-016299EDGAR
2022-11-142022-09-300001493152-22-031641EDGAR
2022-08-152022-06-300001493152-22-022599EDGAR
2022-05-162022-03-310001493152-22-013522EDGAR

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-310001493152-26-013816EDGAR3K words
2026-03-230001493152-26-012164EDGAR
2026-02-050001493152-26-005203EDGAR
2026-01-070001493152-26-000841EDGAR
2025-12-310001493152-25-029711EDGAR
2025-11-130001493152-25-022118EDGAR
2025-08-280001493152-25-012417EDGAR
2025-08-050001493152-25-011597EDGAR
2025-07-280001493152-25-011440EDGAR
2025-07-230001641172-25-020652EDGAR

401 total filings indexed. 369 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0000749647
TickerIMNN
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 6ad15ab44183d6bc97b600c5bcea36730a878034c3b1e0c6b4c9cf42f3f60d6e
parent: 71e511de996f3bcde8aa1c45982e998e719d1e8abeb0a4e0d9551cdba39f94f7
content hash: 5801c56d78bd268b6101fc034b5d8f375f223b65dbe949ea6ed404994e195ef9
signed: 2026-04-13T04:45:40.619Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf